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Abstract: Coronary bifurcations exhibit localized turbulent flow and enhanced propensity for platelet de-
position, plaque rupture, and atherothrombosis. Percutaneous coronary intervention (PCI) of bifurcation
lesions is associated with an increased risk of thrombotic events. Such risk is modulated by anatomical
complexity, intraprocedural factors and pharmacological therapy. There is no consensus on the appropri-
ate PCI strategy or the optimal regimen and duration of antithrombotic treatment in order to decrease
the risk of ischemic and bleeding complications in the setting of coronary bifurcation. A uniform ther-
apeutic approach meets a clinical need. The present initiative, promoted by the European Bifurcation
Club (EBC), involves opinion leaders from Europe, America, and Asia with the aim to analyze the cur-
rently available evidence. Although mainly derived from sub-studies of large trials or small studies, or
from authors’ opinions, an algorithm for the optimal management of patients undergoing bifurcation
PCI, developed on the basis of clinical presentation, bleeding risk, and intraprocedural strategy is here
proposed.
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